Company Profile

NABsys Inc (AKA: Nab Sys Inc)
Profile last edited on: 3/3/2023      CAGE: 4LFM6      UEI: JJF3CLN56NN7

Business Identifier: Development of solid-state, single-molecule positional sequencing technology
Year Founded
2004
First Award
2007
Latest Award
2008
Program Status
Inactive
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

60 Clifford Street
Providence, RI 02903
   (401) 276-9100
   info@nabsys.com
   www.nabsys.com
Location: Single
Congr. District: 01
County: Providence

Public Profile

Having been the first company to receive a "$1000 Genome" award from the National Human Genome Research Institute of the National Institutes of Health for an electronic approach to sequencing DNA, Nabsys uses proprietary electronic nano-channel detectors to analyze long DNA molecules at high velocity. Electronic detection enables Nabsys to achieve significantly higher resolution than can be obtained using optical mapping methods. Nabsys HD-Mapping™ solid-state electronic nano-channel detectors build whole genome maps with sub-diffraction-limit resolution that are truly high definition. These maps offer compelling advantages for the analysis of structural variation, the assembly of genomes, and as a method for confirming putative variants called using other technologies. HD-Mapping works by adding sequence-specific tags to long DNA molecules. These molecules pass through the nano-detectors at high velocity using a combination of electrophoretic and hydrodynamic control. The detectors report the locations of the sequence-specific tags on the molecules. The information is then analyzed by Nabsys analytical software. Key application areas that are enabled by Nabsys include: • De Novo Assembly • Structural Variant Discovery • Variant Verification • Microbiome Analysis • Metagenome Characterization • Hybrid Assembly Nabsys provides the complete solution for electronic genome mapping. The Nabsys HD-Mapping platform includes: • HD-Mapping instrument • Electronic nano-channel detector chips • Complete run reagent cartridge • Sample prep kit • Comprehensive control and data analysis software. Nabsys HD Mapping provides routine, accurate, cost-effective analysis of genomic structural information. The HD-Mapping platform employs fully electronic detection of tagged single DNA molecules to provide significantly higher sensitivity, accuracy, scalability and speed of detection in comparison to existing mapping technologies. Single-molecule reads, hundreds of kilobases in length, have high resolution and low error rates, resulting in high information content per read.

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
25-49
Revenue Range
2.5M-5M
VC funded?
Yes
Public/Private
Privately Held
Stock Info
----
IP Holdings
20-24

Awards Distribution by Agency

Most Recent SBIR Projects

Year Phase Agency Total Amount
2008 2 NIH $497,734
Project Title: Hybridization-Assisted Nanopore Sequencing

Key People / Management

  Barrett Bready -- Founder and CEO

  Jennifer Davis -- Associate Director

  Mike Kaiser -- Vice President of Software & Informatics

  Darren Lee -- Vice President Business Development

  Steve Numberg -- Executive VP of Product Development

  John S Oliver -- Chief Technology Officer

  Brian Paras -- Vice President of Commercial Development